Immature erythroid cell precursors from 12-and 13-day fetal mouse livers were concentrated by differential antibody-mediated hemolysis. The effect of erythropoietin on these purified erythroid cell precursors was studied in vitro. Addition of erythropoietin stimulates erythroid cells to proliferate, and to differentiate to cells that actively synthesize hemoglobin. This erythropoietininduced erythropoiesis is sustained in culture for at least 48 hr.
Elucidation of the cellular and molecular effects of erythropoietin has been aided by the development of several in vitro systems, including the short-term culture of bone marrow (1) and fetal hepatic erythroid cells (2, 3) . However, interpretation of these studies is hindered by the presence of large numbers of differentiated hemoglobin-synthesizing cells in the culture. Although such cells constitute about 70% of the total cell population in the 13-day fetal mouse liver, previous studies (2) indicate that in this system the primary target cell responsive to erythropoietin is a large, nonhemoglobinized precursor, morphologically indistinguishable from the cells called proerythroblasts, that constitutes less than 10% of the population. The present paper describes a method that uses immunological hemolysis (4) (5) (6) to concentrate immature erythroid cell precursors from the total erythropoietic population of fetal mouse liver. This immature cell population responds to erythropoietin by proliferation of erythroid cell precursors, which differentiate to hemoglobin-synthesizing cells.
MATERIALS AND METHODS
The present procedures for the preparation of antibody to mature mouse erythrocytes are modified from earlier studies of Borsook et al. (4, 5) with antiserum to rabbit erythrocytes and of Minio-Paluello et al. (6) with antiserum to mouse erythrocytes. Rabbits were immunized with erythrocytes obtained from adult C57BL/6J female mice bled by cardiac puncture under ether anesthesia. Heparinized mouse blood was pooled, washed three times with saline, packed, and diluted 1:1 with saline; penicillin was then added. 1-1.5 ml Of the erythrocyte suspension was injected intravenously into the rabbits, via the ear vein, three times a week for 4 weeks. 7 Days after the last injection, the rabbits were bled by heart puncture and the serum was sterilized by Millipore filtration (0.45,um pore size). The sera were tested for complement-dependent hemolysin titer (1: 4000 or greater in each of three antisera prepared, all of which proved satisfactory for differential cell lysis). Rabbit sera were not subjected to heat inactivation.
Timed pregnancies were obtained in hormonally primed C57BL/6J female mice (7); fetal hepatic hemopoietic cells were obtained from 12-or 13-day embryos by mechanical disaggregation of the dissected livers (3) . Cells were collected in ice-cold Waymouth MB752/1 medium (GIBCO Grand Island, N.Y.), supplemented with 10% fetal-calf serum (Microbiological Associates, Bethesda, Md.), 3% chickembryo extract (GIBCO), and 1% penicillin-streptomycin (5000 units of penicillin and 5000,g of streptomycin per ml). The fetal-calf serum was used without inactivation at 560 after preliminary experiments demonstrated no advantage to this procedure.
The required concentration of antiserum and complement was established independently for each lot of complement and each antiserum, by titration, using as end point the complete hemolysis of hemoglobinized erythroblasts from 13-day fetal liver cell suspensions (less than 2% contamination of the final suspension by hemoglobinized cells). Guinea pig complement [reconstituted with complete culture medium from lyophilized Hyland Lab (Los Angeles, Calif.) complement, 0.05 ml of complement per ml of total reaction volume] was added dropwise to a suspension of fetal mouse liver hemopoietic cells (6 X 106 cells/ml) with stirring. Cell clumps were eliminated by passage of the suspension through a nylon filter of pore size 10 l m (Nitex NC-10); The suspension was brought to room temperature and appropriately diluted antiserum was added dropwise to a final cell concentration of 4 X 106 cells/ml; the suspension was refiltered through nylon and incubated for 15 min at room temperature, followed by 5 min at 40, with continuous stirring. The cell suspension was washed twice in ice-cold medium and resuspended to a volume that would have contained the original liver cell suspension at a concentration of 2-6 X 106 cells/ml. The actual cell count, performed as described below, indicated a final cell concentration of about 1 X 100 cells/ml. The entire procedure was done with sterile precautions. After complement-mediated antibody hemolysis with final dilutions of antiserum between 1:500 and 1:1000, there is virtually 100% recovery of proerythroblasts and basophilic erythroblasts, while hemoglobin-containing cells (benzidinepositive polychromatophilic, orthochromic, and yolk sac erythroblasts, as well as non-nucleated erythrocytes and reticulocytes) are almost completely hemolyzed (Fig. 1) . 2% Or less contamination with immature polychromatophilic erythroblasts is observed at antiserum concentrations greater than 1:1000 dilution. At higher dilutions of antiserum, increased contamination of the final suspension with hemoglobinized cells is observed; at lower dilutions (1:250 and lower), the recovery of proerythroblasts and basophilic erythroblasts falls progressively. At these higher antiserum concentrations proerythroblasts are, apparently, more susceptible to injury than basophilic erythroblasts; the reason for this greater susceptibility is not known. Further studies, designed to evaluate the effects of erythropoietin on posthemolysis cell suspensions, were performed on cells exposed to antibody dilutions of 1:650 and 1:1000. No significant differences in total cell number and cytological stages of differentiation in the cultures obtained after treatment with these two dilutions of antibody were observed.
Immature 12-and 13-day fetal hepatic erythroid cell precursors (proerythroblasts and basophilic erythroblasts), after their concentration by antibody-complement hemolysis of more-differentiated stages, were cultured for up to 48 hr in the presence or absence of human urinary erythropoietin.
By 24 hr of culture in the presence of erythropoietin, the number of cells has markedly increased, while in the absence of hormone the cell count is reduced (Fig. 2 and Table 1 ). The increase in cell number in the presence of erythropoietin is most striking in cultures covered with a loose-fitting plastic lid, although sealed cultures also responded. We presume that. differences in oxygenation account for the difference between sealed and unsealed cultures. The distribution of erythroid cells by stage of differentiation differs markedly between cultures with and without the hormone (Fig. 2 and Table 1 ). In hormone-treated cultures, two manifestations of the effect of erythropoietin are recognized. First, there is an increase in total population, accounted for by the appearance of large numbers of hemoglobin-synthesizing polychromatophilic erythroblasts and a few orthochromic erythroblasts. The polychromatophilic erythroblasts are proliferating (benzidine-positive mitotic figures), as well as maturing (cells of decreased size and increased hemoglobin concentration). Second, despite extensive differentiation of hemoglobinizing polychromatophilic erythroblasts, the population of nonhemoglobinized precursors (proerythroblasts and basophilic erythroblasts), although reduced in size, is not depleted. Nonhemoglobinized (benzidine-negative) mitotic figures are present in these cultures. By contrast, in cultures without added hormone, only a small number of cells enter into the hemoglobinized stages, while nonhemoglobinized precursors are strikingly depleted. Those erythroblasts that do initiate hemoglobinization without added hormone are capable of progressive differentiation despite the absence of erythropoietin, as evidenced by morphological maturation of the polychromatophilic erythroblasts and the appearance of small numbers of orthochromic erythroblasts.
By 48 hr of culture, the differences between erythropoietintreated and hormone-free cultures are even more striking ( Fig. 2 and Table 1 ). Hormone-treated cultures increase or sustain their total cell numbers, and there is progressive maturation of the population toward the orthochromic erythroblast stage. Erythropoiesis is sustained by cells of the more-immature stages, including proerythroblasts, basophilic erythroblasts, and young polychromatophilic erythroblasts. In the absence of erythropoietin, there are few, if any, identifiable erythroid cells at 48 hr. The few residual erythroid cells are almost exclusively late orthochromic erythroblasts.
DISCUSSION
In vitro culture of erythropoietic cells provides a system for the study of the cellular and molecular mechanism of action of the hormone erythropoietin. Considerable data now identify the erythropoietin-sensitive cell as an early precursor, distinct from and descended from the multipotent hemopoietic stem cell (10, 11) , and morphologically indistinguishable from the class of cells identified as proerythroblasts (2, 12) . These cells exhibit a marked acceleration of RNA synthesis, demonstrable by radioautography, within 1 Several methods of cell separation dependent upon physical properties of developing erythroblasts have been explored in this and other laboratories. Sedimentation methods, including density gradients (14) and unit-gravity sedimentation (15) have proved unsuccessful, in our hands, to obtain pure populations of nonhemoglobinized erythroid precursors. Exploitation of antigenic differences between immature and mature erythroid cells was suggested by the observations of Borsook and coworkers (4, 5) and Minio-Paluello et al. (6) . Using ferritin-labeled antibody to mature mouse erythrocytes, Minio-Paluello and coworkers (6, 16 ) demonstrated a progressive accumulation and density of antigenic sites on the plasma membrane of differentiating erythroblasts.
In the presence of complement and the appropriate dilution of antiserum, only those cells that have tinctorial evidence of hemoglobin accumulation (benzidine-positive polychromatophilic erythroblasts and more-mature stages) are hemolyzed. Immature, nonhemoglobinized, erythropoietin-responsive cells are recovered in high yield. As previously demonstrated (2, 3), the cellular response to erythropoietin in vitro includes proliferation of differentiating erythroblasts, initiation of hemoglobin synthesis, and preservation by proliferative self-renewal of a pool of immature precursors. In the absence of hormone there is hemoglobinization of only a small fraction of the erythroblasts, which may have been triggered to differentiate just before explantation but had not yet accumulated sufficient surface antigen to be susceptible to hemolysis in the cell separation procedure. In the absence of erythropoietin, immature precursors are neither triggered to replicate nor to differentiate into hemoglobinizing progeny. As a consequence, the population rapidly decreases and erythropoiesis is not sustained (2, 3) . The present impure state of erythropoietin does not permit us to dismiss the possible effects on the culture of contaminants in the preparation. Nevertheless, the present observations, taken together with previous studies (2, 3, 12) , strongly suggest that the primary effect of the hormone in vitro is expressed as accelerated RNA synthesis by precursor cells, followed by cell division and the initiation of hemoglobin synthesis. Effects of erythropoietin on the viability and rate of maturation of differentiating erythroblasts were not specifically tested in these studies and, thus, cannot be definitely excluded. It should now be possible with this in vitro system to test the hypothesis that erythropoietin specifically induces replication of erythroid cell precursors, and differentiation to hemoglobin-synthesizing cells (13) , and to define the initial molecular events that occur upon interaction of erythropoietin with its target cell. These studies can be pursued in the absence of the background of biosynthetic activity that accompanies the maturation of hemoglobinizing erythroblasts.
